Glucotrack Inc (GCTK)

$4.74 -0.15 (-3.07%)
Market Cap 4.40M
Revenue (ttm) 0.00
Net Income (ttm) -22.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.03
Volume 35,700
Avg Vol 811,484
Day's Range N/A - N/A
Shares Out 899,000.00
Stochastic %K 40%
Beta -0.17
Analysts Strong Buy
Price Target N/A

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 842 7715
Address:
301 Route 17 North, Suite 800, Rutherford, United States
roguesama
roguesama Sep. 8 at 3:29 PM
$GCTK
0 · Reply
PennyFun
PennyFun Sep. 7 at 10:37 PM
$GCTK $XBI
0 · Reply
NextRunnerTV
NextRunnerTV Sep. 7 at 10:19 PM
Called $ISPC $VEEE $GCTK Last week near the bottoms before the massive spikes. Get ready for this week and turn notifications on 🚨 HUGE WINNERS COMING 🌙
1 · Reply
HopefulIdiot85
HopefulIdiot85 Sep. 5 at 1:55 PM
$GCTK boy oh boy, some news would really be great right now… 🙄 all this potential and yet nothing.
1 · Reply
SorinC
SorinC Sep. 4 at 10:27 PM
$GCTK red red red
0 · Reply
Deerslayer1998
Deerslayer1998 Sep. 4 at 2:37 PM
$GCTK what happened? The company sure did get quiet lately. All the stuff supposedly in pipeline and no news?? I believe in what they are doing I need news
1 · Reply
Duskfall
Duskfall Sep. 3 at 2:50 PM
$GLMD Aramchol has made significant progress in clinical development: from preclinical findings it has progressed to phase 3 and the results are promising. Especially in terms of reducing fibrosis in NASH/MASH patients. Solid company💯 worth keeping an eye on. Undervalued ×3 $TNFA $GCTK $OCGN
0 · Reply
Ianr93
Ianr93 Sep. 3 at 1:24 PM
$GCTK love the PR they put out
1 · Reply
JJBurch
JJBurch Sep. 3 at 1:21 PM
$TNFA WHOA! SHORT SQUEEZE ALERT JUST ISSUED!! Hang on tight folks. Holy hell Here we GO! $OPEN $NVDA $GCTK
1 · Reply
NinjaRai
NinjaRai Sep. 3 at 12:22 PM
$CARM $GCTK $HWH $PMAX $RAYA
0 · Reply
Latest News on GCTK
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 14, 2025, 4:05 PM EDT - 25 days ago

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Aug 6, 2025, 8:30 AM EDT - 4 weeks ago

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Jul 31, 2025, 8:30 AM EDT - 5 weeks ago

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Glucotrack Announces Repurchase of Series A Warrants

Jul 8, 2025, 8:30 AM EDT - 2 months ago

Glucotrack Announces Repurchase of Series A Warrants

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Jun 25, 2025, 10:40 AM EDT - 2 months ago

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 25, 2025, 8:30 AM EDT - 2 months ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 12, 2025, 9:05 AM EDT - 3 months ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 4, 2025, 8:30 AM EDT - 3 months ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 28, 2025, 8:30 AM EDT - 3 months ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 20, 2025, 8:30 AM EDT - 3 months ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 14, 2025, 5:10 PM EDT - 4 months ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

May 13, 2025, 8:01 AM EDT - 4 months ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 16, 2025, 8:00 AM EDT - 5 months ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Apr 3, 2025, 8:01 AM EDT - 5 months ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 31, 2025, 5:00 PM EDT - 5 months ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Mar 19, 2025, 8:01 AM EDT - 6 months ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 26, 2025, 8:01 AM EST - 6 months ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 12:24 PM EST - 7 months ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Feb 4, 2025, 8:01 AM EST - 7 months ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 29, 2025, 9:00 AM EST - 7 months ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Glucotrack Announces ISO 13485:2016 Certification

Jan 21, 2025, 8:01 AM EST - 8 months ago

Glucotrack Announces ISO 13485:2016 Certification

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 15, 2025, 8:01 AM EST - 8 months ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Glucotrack to Present at TechBio Showcase™ 2025

Jan 7, 2025, 4:05 PM EST - 8 months ago

Glucotrack to Present at TechBio Showcase™ 2025

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Dec 3, 2024, 8:30 AM EST - 9 months ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Nov 14, 2024, 4:30 PM EST - 10 months ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 22, 2024, 9:00 AM EDT - 11 months ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Oct 1, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Sep 3, 2024, 9:00 AM EDT - 1 year ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Aug 5, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 20, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

Jun 13, 2024, 9:19 AM EDT - 1 year ago

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Jun 10, 2024, 10:50 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Jun 5, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

May 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

May 15, 2024, 4:15 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

May 2, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Apr 22, 2024, 2:10 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Apr 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Apr 2, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Mar 12, 2024, 9:30 AM EDT - 1 year ago

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Feb 27, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

Feb 13, 2024, 9:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Jan 2, 2024, 12:33 PM EST - 1 year ago

GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Nov 30, 2023, 5:39 PM EST - 1 year ago

GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE

Nov 13, 2023, 9:00 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE

GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Oct 12, 2023, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS

Aug 31, 2023, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS

GLUCOTRACK ANNOUNCES NEW VP OF MARKETING

Aug 28, 2023, 9:00 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES NEW VP OF MARKETING

GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Jul 25, 2023, 9:00 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

roguesama
roguesama Sep. 8 at 3:29 PM
$GCTK
0 · Reply
PennyFun
PennyFun Sep. 7 at 10:37 PM
$GCTK $XBI
0 · Reply
NextRunnerTV
NextRunnerTV Sep. 7 at 10:19 PM
Called $ISPC $VEEE $GCTK Last week near the bottoms before the massive spikes. Get ready for this week and turn notifications on 🚨 HUGE WINNERS COMING 🌙
1 · Reply
HopefulIdiot85
HopefulIdiot85 Sep. 5 at 1:55 PM
$GCTK boy oh boy, some news would really be great right now… 🙄 all this potential and yet nothing.
1 · Reply
SorinC
SorinC Sep. 4 at 10:27 PM
$GCTK red red red
0 · Reply
Deerslayer1998
Deerslayer1998 Sep. 4 at 2:37 PM
$GCTK what happened? The company sure did get quiet lately. All the stuff supposedly in pipeline and no news?? I believe in what they are doing I need news
1 · Reply
Duskfall
Duskfall Sep. 3 at 2:50 PM
$GLMD Aramchol has made significant progress in clinical development: from preclinical findings it has progressed to phase 3 and the results are promising. Especially in terms of reducing fibrosis in NASH/MASH patients. Solid company💯 worth keeping an eye on. Undervalued ×3 $TNFA $GCTK $OCGN
0 · Reply
Ianr93
Ianr93 Sep. 3 at 1:24 PM
$GCTK love the PR they put out
1 · Reply
JJBurch
JJBurch Sep. 3 at 1:21 PM
$TNFA WHOA! SHORT SQUEEZE ALERT JUST ISSUED!! Hang on tight folks. Holy hell Here we GO! $OPEN $NVDA $GCTK
1 · Reply
NinjaRai
NinjaRai Sep. 3 at 12:22 PM
$CARM $GCTK $HWH $PMAX $RAYA
0 · Reply
SpartanVI
SpartanVI Sep. 3 at 12:21 PM
$HWH $CARM $PMAX $RAYA $GCTK Pmax potential next china to go 🔥⏰️
0 · Reply
HopefulIdiot85
HopefulIdiot85 Sep. 3 at 12:10 PM
$GCTK what apps allow trading outside of pre-market and post-market? That drop from close to open definitely got someone some money.
0 · Reply
Wolfy44
Wolfy44 Sep. 3 at 12:06 AM
$GCTK
0 · Reply
TRADE_N_EAT
TRADE_N_EAT Sep. 2 at 8:37 PM
What a way to kick off the month in the green! 🔥 Parabolic $HWH mover off the 2.71 entry break all the way to 7.77 for a massive +186% move! This is exactly what China tickers can do explosive parabolic runs even without news! Moving profits to $IPDN and some into $GCTK
0 · Reply
roguesama
roguesama Sep. 2 at 8:04 PM
$GCTK
1 · Reply
_www_larval_com_
_www_larval_com_ Sep. 2 at 7:53 PM
$CHSN 9%[27%] $AGH 6%[-5%] $VFF -6%[-16%] $SOGP 5%[82%] $GCTK 5%[20%] most notable movement into the final minutes of trading.
0 · Reply
dmacattack
dmacattack Sep. 2 at 6:45 PM
$GCTK low vol am pump then dumped on vol at open. Happens all the time.
1 · Reply
saitek88
saitek88 Sep. 2 at 6:34 PM
$GCTK $CARM Tomorrow all naive traders will lose MORE money to the 8 figures traders. After momentum traders get out, these stocks will just drift lowers for a few days. People will dump and sell out of frustration. Those 8 figures traders will cover very cheaply. I give you guys warning premarket. Luckily I identify these fade very accurately. Yes sometimes I am wrong but most often I am right. Protect your capital at all cost. Know your enemy move = protect yourself guys. That's all for today. Good luck if you hold.
1 · Reply
saitek88
saitek88 Sep. 2 at 6:22 PM
$GCTK $CARM Most 8 figure traders accumulate excessive wealth in short time by shorting because stocks fell down much faster than going up. Not even 1 single of these traders said they made 8 figures profit by long trades. Yes they short stocks like this premarket. Look at the chart, they already book millions profits in a few hours. Just as you all aware because I don't want to see any small traders lose money.
0 · Reply
saitek88
saitek88 Sep. 2 at 6:17 PM
$GCTK $CARM Aggressive shorting going on folks. My POV the same as this early morning: take profit or stay at sideline. Protect capital is always the key.
1 · Reply
topstockalerts
topstockalerts Sep. 2 at 5:16 PM
$GCTK trying to consolidate here..
0 · Reply
GoodRunner
GoodRunner Sep. 2 at 5:04 PM
$GCTK Took some to track it and see where this puppy goes later - just needs a bit of volume to moon it - https://fintel.io/ss/us/gctk - keep it tight
1 · Reply